1. Home
  2. KNDI vs MNOV Comparison

KNDI vs MNOV Comparison

Compare KNDI & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNDI
  • MNOV
  • Stock Information
  • Founded
  • KNDI 2002
  • MNOV 2000
  • Country
  • KNDI China
  • MNOV United States
  • Employees
  • KNDI N/A
  • MNOV N/A
  • Industry
  • KNDI Auto Manufacturing
  • MNOV Biotechnology: Pharmaceutical Preparations
  • Sector
  • KNDI Consumer Discretionary
  • MNOV Health Care
  • Exchange
  • KNDI Nasdaq
  • MNOV Nasdaq
  • Market Cap
  • KNDI 91.2M
  • MNOV 91.7M
  • IPO Year
  • KNDI N/A
  • MNOV 2005
  • Fundamental
  • Price
  • KNDI $1.17
  • MNOV $1.87
  • Analyst Decision
  • KNDI
  • MNOV Strong Buy
  • Analyst Count
  • KNDI 0
  • MNOV 1
  • Target Price
  • KNDI N/A
  • MNOV $9.00
  • AVG Volume (30 Days)
  • KNDI 115.4K
  • MNOV 17.9K
  • Earning Date
  • KNDI 03-13-2025
  • MNOV 02-18-2025
  • Dividend Yield
  • KNDI N/A
  • MNOV N/A
  • EPS Growth
  • KNDI N/A
  • MNOV N/A
  • EPS
  • KNDI N/A
  • MNOV N/A
  • Revenue
  • KNDI $118,127,232.00
  • MNOV N/A
  • Revenue This Year
  • KNDI N/A
  • MNOV N/A
  • Revenue Next Year
  • KNDI N/A
  • MNOV N/A
  • P/E Ratio
  • KNDI N/A
  • MNOV N/A
  • Revenue Growth
  • KNDI N/A
  • MNOV N/A
  • 52 Week Low
  • KNDI $0.89
  • MNOV $1.12
  • 52 Week High
  • KNDI $2.98
  • MNOV $2.55
  • Technical
  • Relative Strength Index (RSI)
  • KNDI 56.77
  • MNOV 42.84
  • Support Level
  • KNDI $1.06
  • MNOV $1.82
  • Resistance Level
  • KNDI $1.12
  • MNOV $1.97
  • Average True Range (ATR)
  • KNDI 0.06
  • MNOV 0.07
  • MACD
  • KNDI 0.00
  • MNOV -0.00
  • Stochastic Oscillator
  • KNDI 60.87
  • MNOV 20.83

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

Share on Social Networks: